Variables in fabrics, fit, and user behavior can influence how well a mask might block the virus’s spread.
Thought leaders in life sciences weigh in on lessons learned amid the COVID-19 pandemic
Scientists look to convalescent plasma, hyperimmune therapy, and monoclonal antibodies to treat COVID-19.
Treatment for rare blood cancers could temper cytokine storm in people with severe forms of the disease.
Regulators are restricting reusable bags over worries they might harbor virus.
Delayed postdoc opportunities. Canceled commencement. Graduate students in chemistry describe how the COVID-19 pandemic has affected their work and lives.
As gene-based vaccines are being designed and tested at unprecedented speeds to fight COVID-19, scientists wonder if this will be the technology’s make-or-break moment.
With university labs shuttered by COVID-19, chemistry faculty are getting a crash course in how to stay productive.
With a diagnostic backlog hampering disease control efforts, scientists are turning to CRISPR and other technologies to bridge the gap
Trafficked scaly anteaters found to carry coronaviruses related to SARS-CoV-2.
The chemist wants the Gates Foundation–backed institute to share its expertise during the coronavirus pandemic and advocate for public health
Open-access collection contains nearly 50,000 chemical compounds from the CAS Registry
Editors in Europe and the US plan to work with authors whose lives and labs have been disrupted by the novel coronavirus
These biomolecules could hold clues to why the virus is so infectious and to how to stop it
Drugmakers want to keep trials going but acknowledge that medical resources are strained
C&EN advice columnist offers 4 tips on adapting to times of uncertainty
Auto manufacturing is the first sector to halt demand for chemicals
Lingering logistic problems and a sputtering economy mean hard times for companies
Activists say broad lack of enforcement threatens safety
Gilead Sciences’ antiviral is in multiple late-stage trials to treat coronavirus infections. Don’t expect a home run, say infectious disease experts
The National Institutes of Health receives the vast majority of the support
The nucleoside inhibitor has advantages over Gilead’s remdesivir but has yet to be tested in humans
Old anti-malarial drugs are tested as potential treatments for COVID-19
Italian workers threaten to strike, but German, UK companies and workers pull together
Many are FDA-approved drugs that could be repurposed
Chemistry CROs are back in business as rest of world starts to lock down
Industry is deemed essential critical infrastructure by federal and state governments
Amid university shutdowns worldwide, professors and students adjust what social distancing means for lab scientists
Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for the virus causing COVID-19
Veterans of teaching chemistry online offer advice for professors challenged by the COVID-19 pandemic
Companies are making their machines and expertise available to hospitals in need of parts
Useful when you don’t have access to a sink and some soap, hand sanitizers have become a hot commodity in the face of COVID-19
Boston biotech firm is making its discovery and production service available to firms working on diagnostics, treatments, and vaccines
Chemical companies, breweries, and perfumeries take to making and donating a vital commodity in short supply
WHO does not recommend against taking the drug for fever caused by novel coronavirus infection
Qiagen vows to ramp up production of kits as scientists turn to social media to plea for donations
New study explores whether dampening IL-6 could address serious coronavirus infections
The German firm will work with Fosun Pharma and Pfizer to develop an mRNA vaccine for COVID-19
Chemical makers and oil producers are pulling back on production, reconsidering investments
Specialty chemical CEOs are rolling with the punches to keep their firms going
The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2–specific data are lacking
Several approved and well-studied small molecules could be repurposed as treatments for COVID-19
Chemical makers brace for a slowdown on the continent
Hear what C&EN’s pharmaceutical editors have learned about how the coronavirus is affecting drug production in China and across the globe
C&EN looks at how scientists are adapting to travel restrictions and working from home
Spring lineup of conferences and events frequented by chemists is slashed
Concerns over the spread of the novel coronavirus leads to decision
Congress opts for open-ended support for federal and local agencies
The structure shows the first steps of SARS-CoV-2 infection, and could help in drug discovery
Petrochemical and pharma meeting organizers say travel was becoming too difficult; ACS spring meeting is still on
The tests can still be used, CDC says, as urgency over possible outbreak grows
Industry watchers say the effort is unprecedented and would not have been possible during the last SARS outbreak
Gilead has a head start on an antiviral, while Moderna is pursuing a novel mRNA vaccine
Facilities are reopening in China but spread of virus outside China is raising concerns
Medical workers in China weigh the advantages and disadvantages of nucleic acid lab tests and CT lung scans
Cryo-EM structure of key coronavirus protein could help develop vaccines against the virus
The industry’s reliance on China-based firms for chemistry services is in the spotlight
Scientists race to characterize, build vaccines and treatments for the virus as thousands fall ill
Firms signal preparedness, but warn that prolonged plant closures and travel restrictions may cause significant disruption
One group identifies an existing drug, the other finds 6 novel molecules, but the consequences of reporting possibly helpful molecules are unclear
Executives in China and the US see a manageable crisis but also many unknowns
Development of diagnostics, vaccines, and treatments is underway
Companies are quick to announce plans to diagnose or treat the novel coronavirus
Influenza evolution experts tell Stereo Chemistry what makes the virus so good at evading our immune system